Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

June 01, 2013; Volume 83,Issue 6

Articles

  • You have access
    PDE3 and PDE4 Isozyme-Selective Inhibitors Are Both Required for Synergistic Activation of Brown Adipose Tissue
    Stephen M. Kraynik, Robert S. Miyaoka and Joseph A. Beavo
    Molecular Pharmacology June 2013, 83 (6) 1155-1165; DOI: https://doi.org/10.1124/mol.112.084145
  • You have access
    Repressive Epigenetic Changes at the mGlu2 Promoter in Frontal Cortex of 5-HT2A Knockout Mice
    Mitsumasa Kurita, José L. Moreno, Terrell Holloway, Alexey Kozlenkov, Giuseppe Mocci, Aintzane García-Bea, James B. Hanks, Rachael Neve, Eric J. Nestler, Scott J. Russo and Javier González-Maeso
    Molecular Pharmacology June 2013, 83 (6) 1166-1175; DOI: https://doi.org/10.1124/mol.112.084582
  • You have access
    Nicotine-Induced Structural Plasticity in Mesencephalic Dopaminergic Neurons Is Mediated by Dopamine D3 Receptors and Akt-mTORC1 Signaling
    Ginetta Collo, Federica Bono, Laura Cavalleri, Laura Plebani, Stefania Mitola, Emilio Merlo Pich, Mark J. Millan, Michele Zoli, Uwe Maskos, PierFranco Spano and Cristina Missale
    Molecular Pharmacology June 2013, 83 (6) 1176-1189; DOI: https://doi.org/10.1124/mol.113.084863
  • You have access
    Pregnane X Receptor Mediates Dyslipidemia Induced by the HIV Protease Inhibitor Amprenavir in Mice
    Robert N. Helsley, Yipeng Sui, Ni Ai, Se-Hyung Park, William J. Welsh and Changcheng Zhou
    Molecular Pharmacology June 2013, 83 (6) 1190-1199; DOI: https://doi.org/10.1124/mol.113.085753
  • You have access
    State-Dependent Etomidate Occupancy of Its Allosteric Agonist Sites Measured in a Cysteine-Substituted GABAA Receptor
    Deirdre S. Stewart, Mayo Hotta, Rooma Desai and Stuart A. Forman
    Molecular Pharmacology June 2013, 83 (6) 1200-1208; DOI: https://doi.org/10.1124/mol.112.084558
  • You have access
    Evidence That Cytochrome b5 and Cytochrome b5 Reductase Can Act as Sole Electron Donors to the Hepatic Cytochrome P450 System
    Colin J. Henderson, Lesley A. McLaughlin and C. Roland Wolf
    Molecular Pharmacology June 2013, 83 (6) 1209-1217; DOI: https://doi.org/10.1124/mol.112.084616
  • You have access
    Transport Function and Transcriptional Regulation of a Liver-Enriched Human Organic Anion Transporting Polypeptide 2B1 Transcriptional Start Site Variant
    Michael J. Knauer, Anthea J. Girdwood, Richard B. Kim and Rommel G. Tirona
    Molecular Pharmacology June 2013, 83 (6) 1218-1228; DOI: https://doi.org/10.1124/mol.112.083618
  • You have access
    Tumor Suppressor Protein p53 Negatively Regulates Human Pregnane X Receptor Activity
    Ayesha Elias, Jing Wu and Taosheng Chen
    Molecular Pharmacology June 2013, 83 (6) 1229-1236; DOI: https://doi.org/10.1124/mol.113.085092
  • You have access
    A Re-Evaluation of the Role of hCTR1, the Human High-Affinity Copper Transporter, in Platinum-Drug Entry into Human Cells
    Kristin D. Ivy and Jack H. Kaplan
    Molecular Pharmacology June 2013, 83 (6) 1237-1246; DOI: https://doi.org/10.1124/mol.113.085068
  • You have access
    Inhibition of Platelet-Derived Growth Factor Receptor α by MEDI-575 Reduces Tumor Growth and Stromal Fibroblast Content in a Model of Non-Small Cell Lung Cancer
    Naomi Laing, Brenda McDermott, Shenghua Wen, David Yang, Deborah Lawson, Mike Collins, Corinne Reimer, Peter A. Hall, Harriet Andersén, Michael Snaith, Xin Wang, Vahe Bedian, Zhu A. Cao and David Blakey
    Molecular Pharmacology June 2013, 83 (6) 1247-1256; DOI: https://doi.org/10.1124/mol.112.084079
  • You have access
    Structure-Based Identification of OATP1B1/3 Inhibitors
    Tom De Bruyn, Gerard J. P. van Westen, Adriaan P. IJzerman, Bruno Stieger, Peter de Witte, Patrick F. Augustijns and Pieter P. Annaert
    Molecular Pharmacology June 2013, 83 (6) 1257-1267; DOI: https://doi.org/10.1124/mol.112.084152
  • You have access
    Therapeutic Cleavage of Anti–Aquaporin-4 Autoantibody in Neuromyelitis Optica by an IgG-Selective Proteinase
    Lukmanee Tradtrantip, Nithi Asavapanumas and A. S. Verkman
    Molecular Pharmacology June 2013, 83 (6) 1268-1275; DOI: https://doi.org/10.1124/mol.113.086470

Erratum

  • You have access
    Correction to “Design and In Vitro Pharmacology of a Selective γ-Aminobutyric AcidC Receptor Antagonist”
    Molecular Pharmacology June 2013, 83 (6) 1276; DOI: https://doi.org/10.1124/mol.113.06er13
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 83 (6)
Molecular Pharmacology
Vol. 83, Issue 6
1 Jun 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Articles
  • Erratum
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics